Education
About Us
Working with TipRanks
Follow Us
Tilray (TLRY)
NASDAQ:TLRY
TLRY Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.35 - $1.95
Previous CloseN/A
Volume22.72M
Average Volume (3M)68.99M
Market Cap
$1.13B
Enterprise Value$466.79M
Total Cash (Recent Filing)$248.41M
Total Debt (Recent Filing)$343.91M
Price to Earnings (P/E)―
Beta1.76
Next Earnings
Oct 02, 2025EPS Estimate
-0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.30
Shares Outstanding1,100,530,200
10 Day Avg. Volume110,479,731
30 Day Avg. Volume68,986,931
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.41
Enterprise Value/Revenue0.56
Enterprise Value/Gross Profit1.98
Enterprise Value/Ebitda-0.72
Forecast
1Y Price Target
$0.94Price Target Upside-17.54% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering6
Bulls Say, Bears Say
Bulls Say
EBITDA PerformanceAdj. EBITDA of $9M came in higher vs. analyst's $6.5M estimate, in part from better-than-expected Canadian cannabis gross margins of 40.5%.
International SalesTLRY achieved a new record in international cannabis sales of $22M, owing to robust market growth in Europe.
Bears Say
Beverage SalesBeverage 4Q sales declined -14% and performance was below management's expectations.
Market EnvironmentA lower multiple is warranted due to the challenging craft beer category backdrop, competitive pressure in Canadian cannabis, and lack of clarity regarding the path to federal legalization of cannabis in the U.S.
Sales And EBITDA OutlookManagement lowered their FY25 sales outlook by $50M to $850M-$900M owing to SKU rationalization efforts.
Tilray News
TLRY FAQ
What was Tilray’s price range in the past 12 months?
Tilray lowest stock price was $0.35 and its highest was $1.95 in the past 12 months.
What is Tilray’s market cap?
Tilray’s market cap is $1.13B.
When is Tilray’s upcoming earnings report date?
Tilray’s upcoming earnings report date is Oct 02, 2025 which is in 43 days.
How were Tilray’s earnings last quarter?
Tilray released its earnings results on Jul 28, 2025. The company reported -$1.3 earnings per share for the quarter, missing the consensus estimate of -$0.024 by -$1.276.
Is Tilray overvalued?
According to Wall Street analysts Tilray’s price is currently Overvalued.
Does Tilray pay dividends?
Tilray does not currently pay dividends.
What is Tilray’s EPS estimate?
Tilray’s EPS estimate is -0.03.
How many shares outstanding does Tilray have?
Tilray has 1,100,530,200 shares outstanding.
What happened to Tilray’s price movement after its last earnings report?
Tilray reported an EPS of -$1.3 in its last earnings report, missing expectations of -$0.024. Following the earnings report the stock price went down -17.143%.
Which hedge fund is a major shareholder of Tilray?
Currently, no hedge funds are holding shares in TLRY
Tilray Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$0.94 (-17.54% Downside)
$0.94 (-17.54% Downside)
Blogger Sentiment
Neutral
TLRY Sentiment 60%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 2.4M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $118.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 6.0%
Last 30 Days ▲ 6.8%
Last 30 Days ▲ 6.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-41.23%
12-Months-Change
Fundamentals
Return on Equity
-88.27%
Trailing 12-Months
Asset Growth
-51.18%
Trailing 12-Months
Company Description
Tilray
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.
TLRY Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflected a mixed performance with strong international cannabis revenue and improved financial metrics, but was offset by significant noncash impairment charges and underperformance in the beverage segment.View all TLRY earnings summariesTLRY Stock 12 Month Forecast
Average Price Target
$0.94
▼(-17.54% Downside)
Technical Analysis
Ownership Overview
0.77% Insiders
0.37% Mutual Funds
1.16% Other Institutional Investors
96.91% Public Companies and Individual Investors